Selective alanine transporter utilization creates a targetable metabolic niche in pancreatic cancer

per Parker, Seth J., Amendola, Caroline R., Hollinshead, Kate E. R., Yu, Qijia, Yamamoto, Keisuke, Encarnación-Rosado, Joel, Rose, Rebecca E., LaRue, Madeleine M., Sohn, Albert S. W., Biancur, Doug E., Paulo, Joao A., Gygi, Steven P., Jones, Drew R., Wang, Huamin, Philips, Mark R., Bar-Sagi, Dafna, Mancias, Joseph D., Kimmelman, Alec C.
Publicat a Cancer Discov (2020)